Literature DB >> 12665649

Follicular, papillary, and "hybrid" carcinomas of the thyroid.

Patrícia Castro1, Elsa Fonseca, João Magalhães, Manuel Sobrinho-Simões.   

Abstract

The existence of well-differentiated thyroid tumors sharing the clinicopathologic features of follicular and papillary carcinoma is discussed using the so-called diffuse (multinodular) form of the follicular variant of papillary carcinoma as a paradigm. Although the concept of a hybrid carcinoma of the thyroid is intellectually very appealing, we conclude that there is not (yet) enough reliable genotypic or phenotypic evidence to support utilization of such a term.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12665649     DOI: 10.1385/ep:13:4:313

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  39 in total

1.  Why there is the tendency to "overdiagnose" the follicular variant of papillary thyroid carcinoma.

Authors:  Andrew A Renshaw; Edwin W Gould
Journal:  Am J Clin Pathol       Date:  2002-01       Impact factor: 2.493

2.  Strict criteria should be applied in the diagnosis of encapsulated follicular variant of papillary thyroid carcinoma.

Authors:  John K C Chan
Journal:  Am J Clin Pathol       Date:  2002-01       Impact factor: 2.493

Review 3.  Hürthle cell tumours of the thyroid. A review with emphasis on mitochondrial abnormalities with clinical relevance.

Authors:  V Máximo; M Sobrinho-Simões
Journal:  Virchows Arch       Date:  2000-08       Impact factor: 4.064

4.  Encapsulated follicular variant of papillary thyroid carcinoma with bone metastases.

Authors:  Z W Baloch; V A LiVolsi
Journal:  Mod Pathol       Date:  2000-08       Impact factor: 7.842

5.  The RET/PTC oncogene is frequently activated in oncocytic thyroid tumors (Hurthle cell adenomas and carcinomas), but not in oncocytic hyperplastic lesions.

Authors:  Gennaro Chiappetta; Paolo Toti; Francesco Cetta; Ada Giuliano; Francesca Pentimalli; Ida Amendola; Stefano Lazzi; Mario Monaco; Luca Mazzuchelli; Piero Tosi; Massimo Santoro; Alfredo Fusco
Journal:  J Clin Endocrinol Metab       Date:  2002-01       Impact factor: 5.958

6.  E-cadherin gene alterations are rare events in thyroid tumors.

Authors:  P Soares; G Berx; F van Roy; M Sobrinho-Simões
Journal:  Int J Cancer       Date:  1997-01-06       Impact factor: 7.396

7.  Anomalous papillary carcinoma of the thyroid.

Authors:  J V Johannessen; M Sobrinões; T Lindmo; K O Tangen; O Kaalhus; I O Brennhovd
Journal:  Cancer       Date:  1983-04-15       Impact factor: 6.860

8.  Ultrastructural morphometry of thyroid neoplasms.

Authors:  J V Johannessen; M Sobrinho-Simóes; I Finseth; L Pilström
Journal:  Am J Clin Pathol       Date:  1983-02       Impact factor: 2.493

9.  Metastatic thyroid carcinoma arising from congenital goiter due to mutation in the thyroperoxidase gene.

Authors:  G Medeiros-Neto; M J Gil-Da-Costa; C L Santos; A M Medina; J C Silva; R M Tsou; M Sobrinho-Simões
Journal:  J Clin Endocrinol Metab       Date:  1998-11       Impact factor: 5.958

10.  A flow cytometric deoxyribonucleic acid analysis of papillary thyroid carcinoma.

Authors:  J V Johannessen; M Sobrinho-Simões; K O Tangen; T Lindmo
Journal:  Lab Invest       Date:  1981-10       Impact factor: 5.662

View more
  10 in total

1.  Difficult cases of thyroid pathology.

Authors:  Manuel Sobrinho-Simões
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

Review 2.  Diagnostic criteria in well-differentiated thyroid carcinomas.

Authors:  Elsa Fonseca; Paula Soares; Manuel Cardoso-Oliveira; Manuel Sobrinho-Simões
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

Review 3.  Molecular pathology of well-differentiated thyroid carcinomas.

Authors:  Manuel Sobrinho-Simões; Ana Preto; Ana Sofia Rocha; Patrícia Castro; Valdemar Máximo; Elsa Fonseca; Paula Soares
Journal:  Virchows Arch       Date:  2005-09-28       Impact factor: 4.064

4.  Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness.

Authors:  Vítor Trovisco; Paula Soares; Ana Preto; Inês Vieira de Castro; Jorge Lima; Patrícia Castro; Valdemar Máximo; Tiago Botelho; Severina Moreira; Ana Margarida Meireles; João Magalhães; Alexander Abrosimov; José Cameselle-Teijeiro; Manuel Sobrinho-Simões
Journal:  Virchows Arch       Date:  2005-05-19       Impact factor: 4.064

5.  Cancer: Small papillary thyroid cancers--is BRAF of prognostic value?

Authors:  Paula Soares; Manuel Sobrinho-Simões
Journal:  Nat Rev Endocrinol       Date:  2011-01       Impact factor: 43.330

6.  Intratumoural lymph vessel density is related to presence of lymph node metastases and separates encapsulated from infiltrative papillary thyroid carcinoma.

Authors:  C Eloy; J Santos; P Soares; M Sobrinho-Simões
Journal:  Virchows Arch       Date:  2011-11-12       Impact factor: 4.064

7.  The preeminence of growth pattern and invasiveness and the limited influence of BRAF and RAS mutations in the occurrence of papillary thyroid carcinoma lymph node metastases.

Authors:  Catarina Eloy; Joana Santos; Paula Soares; Manuel Sobrinho-Simões
Journal:  Virchows Arch       Date:  2011-07-28       Impact factor: 4.064

8.  TGF-beta/Smad pathway and BRAF mutation play different roles in circumscribed and infiltrative papillary thyroid carcinoma.

Authors:  C Eloy; J Santos; J Cameselle-Teijeiro; P Soares; M Sobrinho-Simões
Journal:  Virchows Arch       Date:  2012-04-20       Impact factor: 4.064

9.  Analysis of Malignant Thyroid Neoplasms with a Striking Rise of Papillary Microcarcinoma in an Endemic Goiter Region.

Authors:  Alka Mary Mathai; K Preetha; S Valsala Devi; Sam Vicliph; Raja Pradeep; Aqib Shaick
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2017-07-20

10.  The Role of the PAX8/PPARgamma Fusion Oncogene in Thyroid Cancer.

Authors:  Kimberly A Placzkowski; Honey V Reddi; Stefan K G Grebe; Norman L Eberhardt; Bryan McIver
Journal:  PPAR Res       Date:  2008-10-29       Impact factor: 4.964

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.